Vincerx Pharma Inc. (VINC)
Vincerx Pharma Statistics
Share Statistics
Vincerx Pharma has 5.23M shares outstanding. The number of shares has increased by 51.66% in one year.
| Shares Outstanding | 5.23M |
| Shares Change (YoY) | 51.66% |
| Shares Change (QoQ) | 22.83% |
| Owned by Institutions (%) | 0.03% |
| Shares Floating | 4.49M |
| Failed to Deliver (FTD) Shares | 390 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 55.65K, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 55.65K |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | 0.05 |
Valuation Ratios
The PE ratio is -0.33 and the forward PE ratio is -2.59. Vincerx Pharma's PEG ratio is 0.
| PE Ratio | -0.33 |
| Forward PE | -2.59 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 3.67 |
| P/FCF Ratio | -0.38 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vincerx Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.
| Current Ratio | 1.21 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-2.51M |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -98.7% in the last 52 weeks. The beta is 1.39, so Vincerx Pharma's price volatility has been higher than the market average.
| Beta | 1.39 |
| 52-Week Price Change | -98.7% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 7.28 |
| Relative Strength Index (RSI) | 22.22 |
| Average Volume (20 Days) | 1.1M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -31.46M |
| Net Income | -30.07M |
| EBITDA | -31.46M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -15.85 |
Balance Sheet
The company has 4.99M in cash and 0 in debt, giving a net cash position of 4.99M.
| Cash & Cash Equivalents | 4.99M |
| Total Debt | 0 |
| Net Cash | 4.99M |
| Retained Earnings | -189.19M |
| Total Assets | 8.01M |
| Working Capital | 1.13M |
Cash Flow
In the last 12 months, operating cash flow was -26.13M and capital expenditures 0, giving a free cash flow of -26.13M.
| Operating Cash Flow | -26.13M |
| Capital Expenditures | 0 |
| Free Cash Flow | -26.13M |
| FCF Per Share | -13.77 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VINC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for VINC is $40, which is 15284.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $40 |
| Price Target Difference | 15284.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jan 28, 2025. It was a backward split with a ratio of 1:20.
| Last Split Date | Jan 28, 2025 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -45.57 |
| Piotroski F-Score | 2 |